Ribosomal protein S14 negatively regulates c-Myc activity.

Ribosomal proteins: functions beyond the ribosome. J Mol Cell Biol (2015) 0.99

Ribosomal proteins and human diseases: pathogenesis, molecular mechanisms, and therapeutic implications. Med Res Rev (2014) 0.98

Cyclic avian mass mortality in the northeastern United States is associated with a novel orthomyxovirus. J Virol (2014) 0.89

MYC cofactors: molecular switches controlling diverse biological outcomes. Cold Spring Harb Perspect Med (2014) 0.88

Ribosomopathies: mechanisms of disease. Clin Med Insights Blood Disord (2014) 0.80

The ribosomal protein gene RPL5 is a haploinsufficient tumor suppressor in multiple cancer types. Oncotarget (2017) 0.80

Ribosomal Proteins Control or Bypass p53 during Nucleolar Stress. Int J Mol Sci (2017) 0.79

Ribosomal Proteins Rpl22 and Rpl22l1 Control Morphogenesis by Regulating Pre-mRNA Splicing. Cell Rep (2017) 0.77

Regulatory Roles of Rpl22 in Hematopoiesis: An Old Dog with New Tricks. Crit Rev Immunol (2015) 0.77

Human MageB2 Protein Expression Enhances E2F Transcriptional Activity, Cell Proliferation, and Resistance to Ribotoxic Stress. J Biol Chem (2015) 0.77

How Ribosomes Translate Cancer. Cancer Discov (2017) 0.75

The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. Science (1988) 27.01

A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell (1989) 21.54

Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature (1983) 19.76

The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature (1986) 14.56

Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science (1991) 12.00

Identification of RPS14 as a 5q- syndrome gene by RNA interference screen. Nature (2008) 8.38

Reflecting on 25 years with MYC. Nat Rev Cancer (2008) 7.44

MYC oncogenes and human neoplastic disease. Oncogene (1999) 7.28

c-MYC: more than just a matter of life and death. Nat Rev Cancer (2002) 6.73

Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell (1984) 6.71

A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat Cell Biol (2004) 6.61

Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev (2000) 6.54

Nucleolar Arf sequesters Mdm2 and activates p53. Nat Cell Biol (1999) 5.78

Regulation of HDM2 activity by the ribosomal protein L11. Cancer Cell (2003) 5.44

The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation. Proc Natl Acad Sci U S A (2004) 5.37

miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements. Mol Cell (2009) 5.22

p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci U S A (2009) 5.05

Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7. EMBO J (2004) 4.95

Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. EMBO J (1999) 4.69

Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway. Mol Cell Biol (2003) 4.61

The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins. Cell (1998) 4.52

c-Myc regulates mammalian body size by controlling cell number but not cell size. Nature (2001) 4.46

Ribosomopathies: human disorders of ribosome dysfunction. Blood (2010) 4.43

HuR recruits let-7/RISC to repress c-Myc expression. Genes Dev (2009) 4.41

Oncogenic activity of the c-Myc protein requires dimerization with Max. Cell (1993) 4.10

Analysis of C-MYC function in normal cells via conditional gene-targeted mutation. Immunity (2001) 4.09

Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition. Mol Cell Biol (2004) 4.08

Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5. J Biol Chem (2004) 4.05

The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription. Mol Cell (2003) 3.87

The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc. Mol Cell Biol (2000) 3.86

Skp2 regulates Myc protein stability and activity. Mol Cell (2003) 3.85

Signaling to p53: ribosomal proteins find their way. Cancer Cell (2009) 3.84

P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2. Proc Natl Acad Sci U S A (1999) 3.78

A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. Genes Dev (1993) 3.60

How common are extraribosomal functions of ribosomal proteins? Mol Cell (2009) 3.51

Inhibition of HDM2 and activation of p53 by ribosomal protein L23. Mol Cell Biol (2004) 3.31

MYC recruits the TIP60 histone acetyltransferase complex to chromatin. EMBO Rep (2003) 3.24

Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53. Mol Cell (1999) 2.93

A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q- syndrome. Nat Med (2009) 2.89

Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells. Blood (2010) 2.84

Ribosomal protein S7 as a novel modulator of p53-MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function. Oncogene (2007) 2.68

Distinct haematological disorder with deletion of long arm of no. 5 chromosome. Nature (1974) 2.56

p19ARF directly and differentially controls the functions of c-Myc independently of p53. Nature (2004) 2.26

Hierarchical phosphorylation at N-terminal transformation-sensitive sites in c-Myc protein is regulated by mitogens and in mitosis. Mol Cell Biol (1994) 2.01

Ribosomal protein S7 is both a regulator and a substrate of MDM2. Mol Cell (2009) 2.00

The Drosophila F box protein archipelago regulates dMyc protein levels in vivo. Curr Biol (2004) 1.80

Inhibition of c-Myc activity by ribosomal protein L11. EMBO J (2007) 1.78

Cooperation between the ribosomal proteins L5 and L11 in the p53 pathway. Oncogene (2008) 1.60

Myc-ARF (alternate reading frame) interaction inhibits the functions of Myc. J Biol Chem (2004) 1.58

The ATM-related domain of TRRAP is required for histone acetyltransferase recruitment and Myc-dependent oncogenesis. Genes Dev (2001) 1.55

p14ARF directly interacts with Myc through the Myc BoxII domain. Cancer Biol Ther (2006) 1.44

Nucleophosmin interacts directly with c-Myc and controls c-Myc-induced hyperproliferation and transformation. Proc Natl Acad Sci U S A (2008) 1.44

Nucleophosmin and its AML-associated mutant regulate c-Myc turnover through Fbw7 gamma. J Cell Biol (2008) 1.41

Targeted c-myc gene expression in mammary glands of transgenic mice induces mammary tumours with constitutive milk protein gene transcription. EMBO J (1988) 1.41

SSRP1 functions as a co-activator of the transcriptional activator p63. EMBO J (2002) 1.39

Balance of Yin and Yang: ubiquitylation-mediated regulation of p53 and c-Myc. Neoplasia (2006) 1.34

Myc roles in hematopoiesis and leukemia. Genes Cancer (2010) 1.23

Ribosomal protein S14 unties the MDM2-p53 loop upon ribosomal stress. Oncogene (2012) 1.19

Antagonism of Myc functions by Arf. Cancer Cell (2004) 1.19

Ribosomal protein L11 recruits miR-24/miRISC to repress c-Myc expression in response to ribosomal stress. Mol Cell Biol (2011) 1.13

Feedback regulation of c-Myc by ribosomal protein L11. Cell Cycle (2007) 1.02

Ribosomal protein RPS-14 modulates let-7 microRNA function in Caenorhabditis elegans. Dev Biol (2009) 0.90

The tumor suppressor protein HBP1 is a novel c-myc-binding protein that negatively regulates c-myc transcriptional activity. J Biol Chem (2009) 0.88

DNA microarray screening of differential gene expression in bone marrow samples from AML, non-AML patients and AML cell lines. Leuk Res (2004) 0.86

Physical and functional interaction between ribosomal protein L11 and the tumor suppressor ARF. J Biol Chem (2012) 0.85

Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition. Mol Cell Biol (2004) 4.08

Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5. J Biol Chem (2004) 4.05

Signaling to p53: ribosomal proteins find their way. Cancer Cell (2009) 3.84

Ubiquitination regulates PSD-95 degradation and AMPA receptor surface expression. Neuron (2003) 3.62

Aberrant expression of nucleostemin activates p53 and induces cell cycle arrest via inhibition of MDM2. Mol Cell Biol (2008) 2.45

Ceramides modulate programmed cell death in plants. Genes Dev (2003) 2.22

5-fluorouracil activation of p53 involves an MDM2-ribosomal protein interaction. J Biol Chem (2007) 2.13

MDM2 promotes p21waf1/cip1 proteasomal turnover independently of ubiquitylation. EMBO J (2003) 2.13

Electrolytic manipulation of persulfate reactivity by iron electrodes for trichloroethylene degradation in groundwater. Environ Sci Technol (2013) 2.05

Inhibition of c-Myc activity by ribosomal protein L11. EMBO J (2007) 1.78

Crosstalk between c-Myc and ribosome in ribosomal biogenesis and cancer. J Cell Biochem (2008) 1.77

A systematic review of the management of hangman's fractures. Eur Spine J (2005) 1.74

Nucleophosmin is essential for ribosomal protein L5 nuclear export. Mol Cell Biol (2006) 1.72

Mycophenolic acid activation of p53 requires ribosomal proteins L5 and L11. J Biol Chem (2008) 1.65

Regulation of the MDM2-p53 pathway by ribosomal protein L11 involves a post-ubiquitination mechanism. J Biol Chem (2006) 1.62

Mechanism of catheter thrombosis: comparison of the antithrombotic activities of fondaparinux, enoxaparin, and heparin in vitro and in vivo. Blood (2011) 1.51

Prescription pattern and its influencing factors in Chinese county hospitals: a retrospective cross-sectional study. PLoS One (2013) 1.46

A plasmodesmata-localized protein mediates crosstalk between cell-to-cell communication and innate immunity in Arabidopsis. Plant Cell (2011) 1.45

A liver-specific microRNA binds to a highly conserved RNA sequence of hepatitis B virus and negatively regulates viral gene expression and replication. FASEB J (2011) 1.42

14-3-3gamma binds to MDMX that is phosphorylated by UV-activated Chk1, resulting in p53 activation. EMBO J (2006) 1.40

SSRP1 functions as a co-activator of the transcriptional activator p63. EMBO J (2002) 1.39

A key role for ALD1 in activation of local and systemic defenses in Arabidopsis. Plant J (2004) 1.35

Balance of Yin and Yang: ubiquitylation-mediated regulation of p53 and c-Myc. Neoplasia (2006) 1.34

MDMX promotes proteasomal turnover of p21 at G1 and early S phases independently of, but in cooperation with, MDM2. Mol Cell Biol (2007) 1.33

Vital signs: communication between health professionals and their patients about alcohol use--44 states and the District of Columbia, 2011. MMWR Morb Mortal Wkly Rep (2014) 1.32

UV Induces p21 rapid turnover independently of ubiquitin and Skp2. J Biol Chem (2006) 1.30

Ribosomal stress couples the unfolded protein response to p53-dependent cell cycle arrest. J Biol Chem (2006) 1.29

Novel pyrrolopyrimidine-based α-helix mimetics: cell-permeable inhibitors of protein−protein interactions. J Am Chem Soc (2011) 1.29

Binge drinking - United States, 2011. MMWR Surveill Summ (2013) 1.28

p53 serine 392 phosphorylation increases after UV through induction of the assembly of the CK2.hSPT16.SSRP1 complex. J Biol Chem (2002) 1.27

p53 downregulates Down syndrome-associated DYRK1A through miR-1246. EMBO Rep (2011) 1.25

Upregulation of endothelial and inducible nitric oxide synthase expression by reactive oxygen species. Am J Hypertens (2008) 1.25

Divergent roles in Arabidopsis thaliana development and defense of two homologous genes, aberrant growth and death2 and AGD2-LIKE DEFENSE RESPONSE PROTEIN1, encoding novel aminotransferases. Plant Cell (2004) 1.25

Versatile multi-wavelength ultrafast fiber laser mode-locked by carbon nanotubes. Sci Rep (2013) 1.24

Activation of interleukin-32 pro-inflammatory pathway in response to influenza A virus infection. PLoS One (2008) 1.24

SAG/ROC-SCF beta-TrCP E3 ubiquitin ligase promotes pro-caspase-3 degradation as a mechanism of apoptosis protection. Neoplasia (2006) 1.24

Multilevel regression and poststratification for small-area estimation of population health outcomes: a case study of chronic obstructive pulmonary disease prevalence using the behavioral risk factor surveillance system. Am J Epidemiol (2014) 1.23

Reactive and bioactive cationic α-helical polypeptide template for nonviral gene delivery. Angew Chem Int Ed Engl (2011) 1.21

Plasmodesmata: the battleground against intruders. Trends Plant Sci (2011) 1.20

MDM2 inhibits PCAF (p300/CREB-binding protein-associated factor)-mediated p53 acetylation. J Biol Chem (2002) 1.20

Inferior vena cava ligation rapidly induces tissue factor expression and venous thrombosis in rats. Arterioscler Thromb Vasc Biol (2009) 1.19

Crosstalk between the circadian clock and innate immunity in Arabidopsis. PLoS Pathog (2013) 1.19

A small molecule Inauhzin inhibits SIRT1 activity and suppresses tumour growth through activation of p53. EMBO Mol Med (2012) 1.18

Salicylic acid regulates Plasmodesmata closure during innate immune responses in Arabidopsis. Plant Cell (2013) 1.17

Autoregulatory suppression of c-Myc by miR-185-3p. J Biol Chem (2011) 1.16

Modeling spatial accessibility to parks: a national study. Int J Health Geogr (2011) 1.12

Inauhzin and Nutlin3 synergistically activate p53 and suppress tumor growth. Cancer Biol Ther (2012) 1.09

Hepatitis B virus enhances interleukin-27 expression both in vivo and in vitro. Clin Immunol (2008) 1.08

BAG3 gene silencing sensitizes leukemic cells to Bortezomib-induced apoptosis. FEBS Lett (2008) 1.08

Multiple roles of WIN3 in regulating disease resistance, cell death, and flowering time in Arabidopsis. Plant Physiol (2011) 1.07

Prevalence of Healthy Sleep Duration among Adults - United States, 2014. MMWR Morb Mortal Wkly Rep (2016) 1.07

Selective depletion of factor XI or factor XII with antisense oligonucleotides attenuates catheter thrombosis in rabbits. Blood (2014) 1.05

Signaling pathways that regulate the enhanced disease resistance of Arabidopsis "defense, no death" mutants. Mol Plant Microbe Interact (2008) 1.04

Origin of highly pathogenic H5N1 avian influenza virus in China and genetic characterization of donor and recipient viruses. J Gen Virol (2007) 1.02

SCF TrCP1 activates and ubiquitylates TAp63gamma. J Biol Chem (2007) 1.02

Feedback regulation of c-Myc by ribosomal protein L11. Cell Cycle (2007) 1.02

A key role for the Arabidopsis WIN3 protein in disease resistance triggered by Pseudomonas syringae that secrete AvrRpt2. Mol Plant Microbe Interact (2007) 1.02

MDM2 mediates p300/CREB-binding protein-associated factor ubiquitination and degradation. J Biol Chem (2004) 1.01

Negative feedback regulation of IL-32 production by iNOS activation in response to dsRNA or influenza virus infection. Eur J Immunol (2009) 1.01

p300 regulates p63 transcriptional activity. J Biol Chem (2005) 1.01

Nucleostemin: Another nucleolar "Twister" of the p53-MDM2 loop. Cell Cycle (2010) 1.00

A cell-penetrating helical polymer for siRNA delivery to mammalian cells. Mol Ther (2012) 1.00

Scission of the p53-MDM2 Loop by Ribosomal Proteins. Genes Cancer (2012) 1.00

Nucleocapsid protein of SARS-CoV activates the expression of cyclooxygenase-2 by binding directly to regulatory elements for nuclear factor-kappa B and CCAAT/enhancer binding protein. Int J Biochem Cell Biol (2006) 1.00

Ribosomal protein L11 associates with c-Myc at 5 S rRNA and tRNA genes and regulates their expression. J Biol Chem (2010) 0.99

Reliability of classification systems for intertrochanteric fractures of the proximal femur in experienced orthopaedic surgeons. Injury (2005) 0.98

Evaluation and quantitation of intact wax esters of human meibum by gas-liquid chromatography-ion trap mass spectrometry. Invest Ophthalmol Vis Sci (2012) 0.98

MiR-1246: a new link of the p53 family with cancer and Down syndrome. Cell Cycle (2012) 0.98

Epigenetic changes mediated by microRNA miR29 activate cyclooxygenase 2 and lambda-1 interferon production during viral infection. J Virol (2011) 0.97

MDM2 mediates ubiquitination and degradation of activating transcription factor 3. J Biol Chem (2010) 0.97

Dietary selenium intake, aldehyde dehydrogenase-2 and X-ray repair cross-complementing 1 genetic polymorphisms, and the risk of esophageal squamous cell carcinoma. Cancer (2006) 0.97

Ubiquitin- and MDM2 E3 ligase-independent proteasomal turnover of nucleostemin in response to GTP depletion. J Biol Chem (2012) 0.97

Novel method for the rapid isolation of RPE cells specifically for RNA extraction and analysis. Exp Eye Res (2012) 0.96

Interferon-inducible protein IFIXalpha1 functions as a negative regulator of HDM2. Mol Cell Biol (2006) 0.96

Inauhzin sensitizes p53-dependent cytotoxicity and tumor suppression of chemotherapeutic agents. Neoplasia (2013) 0.96

Methylselenol prodrug enhances MDV3100 efficacy for treatment of castration-resistant prostate cancer. Int J Cancer (2013) 0.95

A role for SSRP1 in recombination-mediated DNA damage response. J Cell Biochem (2009) 0.95

Human SSRP1 has Spt16-dependent and -independent roles in gene transcription. J Biol Chem (2007) 0.95

Observation of pulse trapping in a near-zero dispersion regime. Opt Lett (2012) 0.95

Global effect of inauhzin on human p53-responsive transcriptome. PLoS One (2012) 0.94

Toward an animal model of the human tear film: biochemical comparison of the mouse, canine, rabbit, and human meibomian lipidomes. Invest Ophthalmol Vis Sci (2012) 0.94

Tunable multi-channel wavelength demultiplexer based on MIM plasmonic nanodisk resonators at telecommunication regime. Opt Express (2011) 0.94

Structure-specific recognition protein 1 facilitates microtubule growth and bundling required for mitosis. Mol Cell Biol (2009) 0.93

CK2 phosphorylates SSRP1 and inhibits its DNA-binding activity. J Biol Chem (2005) 0.93

Reconfiguring the architectures of cationic helical polypeptides to control non-viral gene delivery. Biomaterials (2012) 0.93

Climate-driven speedup of alpine treeline forest growth in the Tianshan Mountains, Northwestern China. Glob Chang Biol (2014) 0.93

Co-transplantation of GDNF-overexpressing neural stem cells and fetal dopaminergic neurons mitigates motor symptoms in a rat model of Parkinson's disease. PLoS One (2013) 0.92

Expression of LINE-1 p40 protein in pediatric malignant germ cell tumors and its association with clinicopathological parameters: a report from the Children's Oncology Group. Cancer Lett (2006) 0.91

Structure and activity analysis of Inauhzin analogs as novel antitumor compounds that induce p53 and inhibit cell growth. PLoS One (2012) 0.90

Major vault protein: a virus-induced host factor against viral replication through the induction of type-I interferon. Hepatology (2012) 0.90

AMP-activated protein kinase induces p53 by phosphorylating MDMX and inhibiting its activity. Mol Cell Biol (2013) 0.90

Hydrophilic residues are crucial for ribosomal protein L11 (RPL11) interaction with zinc finger domain of MDM2 and p53 protein activation. J Biol Chem (2011) 0.89

Circadian clock-regulated phosphate transporter PHT4;1 plays an important role in Arabidopsis defense. Mol Plant (2011) 0.89

Phosphorylation and stabilization of TAp63gamma by IkappaB kinase-beta. J Biol Chem (2008) 0.89

Dimerization and cytoplasmic localization regulate Hippo kinase signaling activity in organ size control. J Biol Chem (2012) 0.89

Academic-health department collaborative relationships are reciprocal and strengthen public health practice: results from a study of academic research centers. J Public Health Manag Pract (2014) 0.89

Nucleation-controlled polymerization of nanoparticles into supramolecular structures. J Am Chem Soc (2013) 0.88